Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin P Gazerani, NS Pedersen, C Staahl, AM Drewes, L Arendt-Nielsen PAIN® 141 (1-2), 60-69, 2009 | 207 | 2009 |
Sex-related differences in pain BE Cairns, P Gazerani Maturitas 63 (4), 292-296, 2009 | 200 | 2009 |
MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions HH Andersen, M Duroux, P Gazerani Neurobiology of Disease 71, 159-168, 2014 | 191 | 2014 |
Addressing potential impact of COVID-19 pandemic on physical and mental health of elite athletes AH Mehrsafar, P Gazerani, AM Zadeh, JCJ Sánchez Brain, behavior, and immunity 87, 147, 2020 | 187 | 2020 |
The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization P Gazerani, C Staahl, AM Drewes, L Arendt-Nielsen Pain 122 (3), 315-325, 2006 | 187 | 2006 |
A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences P Gazerani, OK Andersen, L Arendt-Nielsen Pain 118 (1-2), 155-163, 2005 | 163 | 2005 |
Migraine and diet P Gazerani Nutrients 12 (6), 1658, 2020 | 143 | 2020 |
Pressure pain thresholds assessed over temporalis, masseter, and frontalis muscles in healthy individuals, patients with tension-type headache, and those with migraine—A … S Andersen, MW Petersen, AS Svendsen, P Gazerani Pain 156 (8), 1409-1423, 2015 | 138 | 2015 |
Probiotics for Parkinson’s disease P Gazerani International journal of molecular sciences 20 (17), 4121, 2019 | 135 | 2019 |
Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women P Gazerani, K Wang, BE Cairns, P Svensson, L Arendt-Nielsen Pain 124 (3), 338-348, 2006 | 123 | 2006 |
Determination of metformin in human plasma by high-performance liquid chromatography H Amini, A Ahmadiani, P Gazerani Journal of Chromatography B 824 (1-2), 319-322, 2005 | 106 | 2005 |
The effects of mindfulness training on competition-induced anxiety and salivary stress markers in elite Wushu athletes: A pilot study AH Mehrsafar, J Strahler, P Gazerani, M Khabiri, JCJ Sánchez, ... Physiology & behavior 210, 112655, 2019 | 104 | 2019 |
Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine … P Gazerani, S Au, X Dong, U Kumar, L Arendt-Nielsen, BE Cairns PAIN® 151 (3), 606-616, 2010 | 94 | 2010 |
Botulinum toxin type a as a therapeutic agent against headache and related disorders S Luvisetto, P Gazerani, C Cianchetti, F Pavone Toxins 7 (9), 3818-3844, 2015 | 92 | 2015 |
Botulinum toxin type A reduces histamine‐induced itch and vasomotor responses in human skin P Gazerani, NS Pedersen, AM Drewes, L Arendt‐Nielsen British Journal of Dermatology 161 (4), 737-745, 2009 | 84 | 2009 |
Serum microRNA signatures in migraineurs during attacks and in pain-free periods HH Andersen, M Duroux, P Gazerani Molecular neurobiology 53, 1494-1500, 2016 | 82 | 2016 |
Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model F Dardmeh, H Alipour, P Gazerani, G van der Horst, E Brandsborg, ... PloS one 12 (10), e0185964, 2017 | 80 | 2017 |
A correlation between migraine, histamine and immunoglobulin E P Gazerani, Z Pourpak, A Ahmadiani, A Hemmati, A Kazemnejad Scandinavian journal of immunology 57 (3), 286-290, 2003 | 78 | 2003 |
Glutamate dysregulation in the trigeminal ganglion: a novel mechanism for peripheral sensitization of the craniofacial region JC Laursen, BE Cairns, XD Dong, U Kumar, RK Somvanshi, ... Neuroscience 256, 23-35, 2014 | 69 | 2014 |
Effect of local controlled heat on transdermal delivery of nicotine KK Petersen, ML Rousing, C Jensen, L Arendt-Nielsen, P Gazerani International journal of physiology, pathophysiology and pharmacology 3 (3), 236, 2011 | 69 | 2011 |